Pharmafile Logo
Pharmafocus logo
Advanced Search

Recruitment

Showing 10 posts of 10 posts found.

The Pharma Files: With Priyanka Hinton from CHASE

August 3, 2025 Business Services, Recruitment CHASE, The Pharma Files

Pharmafile chats with Priyanka Hinton, Customer Solutions Director at Chase People about the best parts of her job and her …
Feature

Apiary invests in life sciences SEO pioneer PIO to support global expansion

May 9, 2025 Agency, Business Services, Marketing Consultancies AI, Apiary Capital, Corporate, PIO, SEO, agency, investment, performance marketing, performance-io

Private equity firm Apiary Capital has invested in performance-io (PIO), a specialist life sciences performance marketing and SEO agency, to …
News

Neurizon makes appointments to executive team

April 24, 2025 Recruitment, Senior Management Neurizon, Neurology, als, biotech, neurodegenerative diseases

Neurizon Therapeutics, a clinical-stage biotech company focusing on treatments for neurodegenerative diseases, has announced three leadership appointments. These will support …
Appointment

AAX Biotech aims to enhance growth with two new appointments

April 10, 2025 Business Development, Recruitment, Research and Development AAX Biotech, Immunology, Oncology, R&D development, antibody therapeutics, business development

AAX Biotech has appointed Ionut Gabriel Dumitru (pictured left) as senior scientist and Kushal Sejwal (pictured right) as business developer, …
Appointment

Shane Olwill appointed as chief development officer at Asgard Therapeutics

March 28, 2025 Business Services, Clinical Research Asgard Therapeutics, CDO, Oncology, appointment, immunology

Asgard Therapeutics has announced the appointment of Shane Olwill as chief development officer (CDO). The biotech company develops in vivo …
Appointment

PulseSight Therapeutics closes Series A financing for dry AMD phase 1 clinical study

February 14, 2025 Clinical Research Opthalmology, age-related macular degeneration, clinical trials

Ophthalmology biotech PulseSight Therapeutics has confirmed the closure of its Series A funding round, the proceeds of which will be …
News

Results from Novadip phase 1b/2a trial reveal 88% efficacy

January 28, 2025 Clinical Research Congenital Pseudoarthritis of the Tibia, Rare Diseases, clinical trials, efficacy, paediatric, rare diseases

Novadip Biosciences, a clinical stage biotechnology company with a specialty in regenerative medicine, has announced the results of its 12-month …
News

China CDE clears Phase 3 Study of Lisafltoclax in Newlly Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome

August 13, 2024 Clinical Research, Research and Development Ascentage Pharma, Oncology

The China Centre for Drug Evaluation (CDE) has cleared the registrational phase 3 study of lisaftoclax in combination with azacitadine …
News

Drug discovery and development partnership announced between Apollo Therapeutics and Oxford University

July 31, 2024 Clinical Research, Medical Communications, Research and Development Apollo Therapeutics, Internal Medicine, Microbiology, drug development, drug discovery, research

Portfolio therapeutics company Apollo Therapeutics has announced earlier this week that it will provide capital and expertise to Oxford University’s …
News

Astellas set to open new life sciences facilities in Cambridge, Massachusetts

August 10, 2023 Business Development Astellas Pharma, Pharmacy, pharmaceutical, science facility

On 9 August 2023, Astellas Pharma announced its plans to open what it has described as a “state-of-the-art life sciences …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026